PDF herunterladen
Seminars in Neurosurgery 2002; 13(1): 047-060
DOI: 10.1055/s-2002-35247
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Neurosurgical Management of Hypertonia in Children

Paul Steinbok
  • Division of Pediatric Neurosurgery, Department of Surgery, University of British Columbia, Canada; and Division of Pediatric Neurosurgery, Section of Surgery, British Columbia's Children's Hospital, Vancouver, British Columbia, Canada
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
04. November 2002 (online)

    Lizenzen und Reprints

ABSTRACT

Hypertonia, whether it is spasticity, dystonia or a combination, is an important clinical problem in children and is most commonly associated with cerebral palsy. In this review of the management of hypertonia in children with cerebral palsy, the multidisciplinary nature of the management is stressed. The various modalities of treatment are discussed, with the emphasis on the neurosurgical aspects of management. The two major neurosurgical treatments, namely selective dorsal rhizotomy and intrathecal baclofen, are reviewed in detail. Current knowledge about outcomes with these treatments is presented according to a paradigm developed by the National Center for Medical Rehabilitation Research. Guidelines are provided for the selection of the different treatment modalities.

KEYWORDS

Spasticity - dystonia - hypertonia - dorsal rhizotomy - intrathecal baclofen - cerebral palsy

REFERENCES

  • 1 Fahn S. Concept and classification of dystonia.  Advances in Neurology . 1988;  50 1-8
    PubMedGoogle Scholar
  • 2 Fahn S, Bressman S B, Marsden C D. Classification of Dystonia. In: Fahn S, Marsden CD, DeLong, M, eds. Dystonia 3 Vol 78. Philadelphia, PA: Lippincott-Raven, 1998: 1-10
    Google Scholar
  • 3 Paneth N, Kiely J. The frequency of cerebral palsy: a review of population studies in industrialized nations since 1950. In: Stanley F, Alberman E, eds. The Epidemiology of the Cerebral Palsies London: Spastics International Medical Publications, 1984: 46-56
    Google Scholar
  • 4 Stanley F J, Blair E. Why have we failed to reduce the incidence of cerebral palsy?.  Medical Journal of Australia . 1991;  154 623-626
    PubMedGoogle Scholar
  • 5 Newacheck P W, Taylor W R. Childhood chronic illness: prevalence, severity and impact.  American Journal of Public Health . 1992;  82 364-371
    PubMedGoogle Scholar
  • 6 Albright A L. Spasticity and movement disorders in cerebral palsy [editorial].  Journal of Child Neurology . 1996;  11 S1-4
    PubMedGoogle Scholar
  • 7 Dabney K W, Lipton G E, Miller F. Cerebral palsy.  Current Opinion in Pediatrics . 1997;  9 81-88
    PubMedGoogle Scholar
  • 8 Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers.  Developmental Medicine and Child Neurology . 2000;  42 816-824
    CrossrefPubMedGoogle Scholar
  • 9 Foerster O. On the indications and results of the excision of posterior spinal nerve roots in man.  Surgery Gynecology and Obstetrics . 1913;  16 463-474
    PubMedGoogle Scholar
  • 10 Gros C. Spasticity: clinical classification and surgical treatment. In: Krayenbujl H, ed. Advances and Technical Standards in Neurosurgery Vol 6. Wien: Springer-Verlag 1979: 55-97
    Google Scholar
  • 11 Gros C, Ooaknine G, Vlahhovitch B, Frerebeau P. La radicotomie selective posterioeure dans le traitment neurochirurgical de l'hypertonie pyramidale.  Neurochirurgie . 1967;  13 505-518
    PubMedGoogle Scholar
  • 12 Privat J M, Benezech J, Frerebeau P, Gros C. Sectorial posterior rhizotomy, a new technique of surgical treatment for spasticity.  Acta Neurochirurgica . 1976;  35 181-195
    CrossrefPubMedGoogle Scholar
  • 13 Fasano V A, Broggi G, Barolat-Romana G, Sguazzi A. Surgical treatment of spasticity in cerebral palsy.  Childs Brain . 1978;  4 289-305
    PubMedGoogle Scholar
  • 14 Fasano V A, Broggi G, Zeme S. Intraoperative electrical stimulation for functional posterior rhizotomy.  Scandinavian Journal of Rehabilitation Medicine . 1988;  17(suppl) S149-S154
    PubMedGoogle Scholar
  • 15 Fasano V A, Broggi G, Zeme S, Lo Russo G, Sguazzi A. Long-term results of posterior functional rhizotomy.  Acta Neurochirurgica-Supplementum . 1980;  30 435-439
    PubMedGoogle Scholar
  • 16 Peacock W J, Arens L J. Selective posterior rhizotomy for the relief of spasticity in cerebral palsy.  South African Medical Journal . 1982;  62 119-124
    PubMedGoogle Scholar
  • 17 Cohen A R, Webster H C. How selective is selective posterior rhizotomy?.  Surgical Neurology . 1991;  35 267-272
    CrossrefPubMedGoogle Scholar
  • 18 Landau W M. Dorsal rhizotomy, a treatment of unproven efficacy.  J Child Neurol . 1990;  5 174-178
    PubMedGoogle Scholar
  • 19 Logigian E L, Wolinsky J S, Soriano S G, Madsen J R, Scott R M. H reflex studies in cerebral palsy patients undergoing partial dorsal rhizotomy.  Muscle & Nerve . 1994;  17 539-549
    PubMedGoogle Scholar
  • 20 Pollack M A. Limited benefit of electrophysiological studies during dorsal rhizotomy.  Muscle & Nerve . 1994;  17 553-556
    PubMedGoogle Scholar
  • 21 Steinbok P, Keyes R, Langill L, Cochrane D D. The validity of electrophysiological criteria used in selective functional posterior rhizotomy for treatment of spastic cerebral palsy.  Journal of Neurosurgery . 1994;  81 354-361
    PubMedGoogle Scholar
  • 22 Weiss I P, Schiff S J. Reflex variability in selective dorsal rhizotomy.  Journal of Neurosurgery . 1993;  79 346-353
    PubMedGoogle Scholar
  • 23 Steinbok P, Kestle J R. Variation between centers in electrophysiologic techniques used in lumbosacral selective dorsal rhizotomy for spastic cerebral palsy.  Pediatric Neurosurgery . 1996;  25 233-239
    PubMedGoogle Scholar
  • 24 Cochrane D D, Steinbok P. Laminotomy: a technical note.  Childs Nervous System . 1992;  8 226-228
    PubMedGoogle Scholar
  • 25 Steinbok P. Outcomes after selective dorsal rhizotomy for spastic cerebral palsy.  Child's Nervous System . 2001;  17 1-18
    PubMedGoogle Scholar
  • 26 Sackett D L. Rules of evidence and clinical recommendations on the use of antithrombotic agents.  Chest . 1986;  39 25-35
    PubMedGoogle Scholar
  • 27 Bullock R, Chestnut R M, Clifton G. Guidelines for the management of severe head injury.  Journal of Neurotrauma . 1996;  13 643-645
    PubMedGoogle Scholar
  • 28 Wright F V, Sheil E M, Drake J M, Wedge J H, Naumann S. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial.  Developmental Medicine & Child Neurology . 1998;  40 239-247
    PubMedGoogle Scholar
  • 29 Hodgkinson I, Berard C, Jindrich M L, Sindou M, Mertens P, Berard J. Selective dorsal rhizotomy in children with cerebral palsy: results in 18 cases at one year postoperatively.  Stereotactic & Functional Neurosurgery . 1997;  69 259-267
    PubMedGoogle Scholar
  • 30 McLaughlin J F, Bjornson K F, Astley S J. The role of selective dorsal rhizotomy in cerebral palsy: critical evaluation of a prospective clinical series.  Developmental Medicine & Child Neurology . 1994;  36 755-769
    PubMedGoogle Scholar
  • 31 McLaughlin J F, Bjornson K F, Astley S J. Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial.  Developmental Medicine & Child Neurology . 1998;  40 220-232
    PubMedGoogle Scholar
  • 32 Steinbok P, Reiner A M, Beauchamp R, Armstrong R W, Cochrane D D. A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy.  Developmental Medicine & Child Neurology . 1997;  39 178-184
    PubMedGoogle Scholar
  • 33 McLaughlin J, Bjornson K, Temkin N. ``Selective'' dorsal rhizotomy: meta-analysis of three randomized controlled trials.  Developmental Medicine and Child Neurology . 2002;  44 17-25
    PubMedGoogle Scholar
  • 34 Bloom K K, Nazar G B. Functional assessment following selective posterior rhizotomy in spastic cerebral palsy.  Childs Nervous System . 1994;  10 84-86
    PubMedGoogle Scholar
  • 35 Dudgeon B J, Libby A K, McLaughlin J F, Hays R M, Bjornson K F, Roberts T S. Prospective measurement of functional changes after selective dorsal rhizotomy.  Archives of Physical Medicine & Rehabilitation . 1994;  75 46-53
    PubMedGoogle Scholar
  • 36 Loewen P, Steinbok P, Holsti L, MacKay M. Upper extremity performance and self-care skill changes with spastic cerebral palsy following selective posterior rhizotomy.  Pediatric Neurosurgery . 1998;  29 191-198
    PubMedGoogle Scholar
  • 37 Nishida T, Thatcher S W, Marty G R. Selective posterior rhizotomy for children with cerebral palsy: a 7-year experience.  Childs Nervous System . 1995;  11 374-380
    PubMedGoogle Scholar
  • 38 Craft S, Park T S, White D A, Schatz J, Noetzel M, Arnold S. Changes in cognitive performance in children with spastic diplegic cerebral palsy following selective dorsal rhizotomy.  Pediatric Neurosurgery . 1995;  23 68-74
    PubMedGoogle Scholar
  • 39 Arens L J, Peacock W J, Peter J. Selective posterior rhizotomy: a long-term follow-up study.  Childs Nervous System . 1989;  5 148-152
    PubMedGoogle Scholar
  • 40 Carroll K L, Moore K R, Stevens P M. Orthopedic procedures after rhizotomy.  Journal of Pediatric Orthopedics . 1998;  18 69-74
    CrossrefPubMedGoogle Scholar
  • 41 Marty G R, Dias L S, Gaebler-Spira D. Selective posterior rhizotomy and soft-tissue procedures for the treatment of cerebral diplegia.  Journal of Bone & Joint Surgery-American Volume . 1995;  77 713-718
    PubMedGoogle Scholar
  • 42 Heim R C, Park T S, Vogler G P, Kaufman B A, Noetzel M J, Ortman M R. Changes in hip migration after selective dorsal rhizotomy for spastic quadriplegia in cerebral palsy.  Journal of Neurosurgery . 1995;  82 567-571
    PubMedGoogle Scholar
  • 43 Park T S, Vogler G P, Phillips II H L. Effects of selective dorsal rhizotomy for spastic diplegia on hip migration in cerebral palsy.  Pediatric Neurosurgery . 1994;  20 43-49
    PubMedGoogle Scholar
  • 44 Abbott R, Johann-Murphy M, Shiminski-Maher T. Selective dorsal rhizotomy: outcome and complications in treating spastic cerebral palsy.  Neurosurgery . 1993;  33 851-857
    PubMedGoogle Scholar
  • 45 Steinbok P, Schrag C. Complications after selective posterior rhizotomy for spasticity in children with cerebral palsy.  Pediatric Neurosurgery . 1998;  28 300-313
    PubMedGoogle Scholar
  • 46 Deletis V, Vodusek D B, Abbott R, Epstein F J, Turndorf H. Intraoperative monitoring of the dorsal sacral roots: minimizing the risk of iatrogenic micturition disorders.  Neurosurgery . 1992;  30 72-75
    PubMedGoogle Scholar
  • 47 Abbott R. Complications with selective posterior rhizotomy.  Pediatric Neurosurgery . 1992;  18 43-47
    PubMedGoogle Scholar
  • 48 Abbott R, Forem S L, Johann M. Selective posterior rhizotomy for the treatment of spasticity: a review.  Childs Nervous System . 1989;  5 337-346
    PubMedGoogle Scholar
  • 49 Abbott R. Sensory rhizotomy for the treatment of childhood spasticity.  Journal of Child Neurology . 1996;  11(suppl) S36-S42
    PubMedGoogle Scholar
  • 50 Peter J C, Arens L J. Selective posterior lumbosacral rhizotomy for the management of cerebral palsy spasticity: a 10-year experience.  South African Medical Journal . 1993;  83 745-747
    PubMedGoogle Scholar
  • 51 Price G W, Wilkin G P, Turnbull M J, Bowery M G. Are baclofen-sensitive GABAB receptors present on primary afferent terminals of the spinal cord?.  Nature . 1984;  307 71-74
    CrossrefPubMedGoogle Scholar
  • 52 Knuttson E, Lindblom U, Beissinger R L, Martenson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paraparesis.  Journal of Neurological Sciences . 1974;  23 473-484
    CrossrefPubMedGoogle Scholar
  • 53 Albright A L. Baclofen in the treatment of cerebral palsy.  Journal of Child Neurology . 1996;  11 77-83
    PubMedGoogle Scholar
  • 54 Van Hemert J CJ. A double blind comparison of baclofen and placebo in patients with spasticity of cerebral origin.  In: Feldman RG, Young RR, Koella WP, eds. Spasticity: Disordered Motor Control. Chicago: Yearbook Medical Publishers 1980: 41-50
    Google Scholar
  • 55 Milla P J, Jackson A DM. A controlled trial of baclofen in children with cerebral palsy.  Journal of International Medical Research . 1977;  5 398-404
    PubMedGoogle Scholar
  • 56 O'Donnell M , Armstrong r . Pharmacologic interventions for management of spasticity in cerebral palsy.   Mental Retardation and Developmental Disabilities Research Review . 1997;  3 204-211
    PubMedGoogle Scholar
  • 57 Muller H , Zierski J , Dralle D , Kraus D , Mutschler E . Pharmacokinetics of intrathecal baclofen.  In: Muller H, Zierski J, Penn RD, eds. Local Spinal Therapy of Spasticity. Berlin: Springer-Verlag 1988: 223-226
    Google Scholar
  • 58 Kroin J S, Ali A , York M , Penn R D. The distribution of medication along the spinal canal after chronic intrathecal administration.  Neurosurgery . 1993;  33 226-230
    CrossrefPubMedGoogle Scholar
  • 59 Ochs G A. GA. Intrathecal baclofen.  Baillieres Clinical Neurology . 1993;  2 73-86
    PubMedGoogle Scholar
  • 60 Muller H , Zierski J , Dralle D , Hoffmann O , Michaelis  G D. Intrathecal baclofen in spasticity.  In: Muller H, Zierski J, Penn RD, eds. Local Spinal Therapy of Spasticity. Berlin: Springer-Verlag 1988: 155-214
    Google Scholar
  • 61 Albright A L, Cervi A , Singletary  J . Intrathecal baclofen for spasticity in cerebral palsy.   Journal of the American Medical Association . 1991;  265 1418-1422
    CrossrefPubMedGoogle Scholar
  • 62 Bohannon R W, Smith  M B. Interrater reliability of a modified Ashworth Scale.  Physical Therapy . 1987;  67 206-207
    PubMedGoogle Scholar
  • 63 Albright  A L. Intrathecal baclofen in cerebral palsy movement disorders.   Journal of Child Neurology . 1996;  11(suppl) S29-S35
    PubMedGoogle Scholar
  • 64 Narayan R K, Loubser  P G, Jankovic J , Donovan  W H, Bontke  C F. Intrathecal baclofen for intractable axial dystonia.  Neurology . 1991;  41 1141-1142
    CrossrefPubMedGoogle Scholar
  • 65 Albright A L, Barry  M J, Fasick P , Barron  W , Shultz B . Continuous intrathecal baclofen infusion for symptomatic generalized dystonia.   Neurosurgery . 1996;  38 934-939
    CrossrefPubMedGoogle Scholar
  • 66 Armstrong R W, Steinbok  P , Cochrane D D, Kube  S D, Fife  S E, Farrell K . Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.  Journal of Neurosurgery . 1997;  87 409-414
    PubMedGoogle Scholar
  • 67 Akman  M N, Loubser  P G, Donovan  W H, O'Neill  M E, Rossi C D. Intrathecal baclofen: does tolerance occur?.  Paraplegia . 1993;  31 516-520
    PubMedGoogle Scholar
  • 68 Coffey  R J, Cahill  D , Steers W . Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.  Journal of Neurosurgery . 1993;  78 226-232
    PubMedGoogle Scholar
  • 69 Hugenholtz  H , Nelson  R F, Dehoux  E , Bickerton R . Intrathecal baclofen for intractable spinal spasticity: a double-blind cross-over comparison with placebo in six patients.  Canadian Journal of Neurological Sciences . 1992;  19 188-195
    PubMedGoogle Scholar
  • 70 Loubser  P , Narayan  R K, Sandin  K J, Donovan  W H, Russell K D. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury.  Paraplegia . 1991;  29 48-64
    PubMedGoogle Scholar
  • 71 Meythaler  J M, Steers  W D, Tuel  S M, Cross  L L, Haworth C S. Continuous intrathecal baclofen in spinal cord spasticity: a prospective study.  American Journal of Physical Medicine & Rehabilitation . 1992;  71 321-327
    PubMedGoogle Scholar
  • 72 Albright  A L, Barron  W B, Fasick M P, Polinko  P , Janosky J . Continuous intrathecal baclofen infusion for spasticity of cerebral origin.  Journal of the American Medical Association . 1993;  270 2475-2477
    CrossrefPubMedGoogle Scholar
  • 73 Albright A L, Barry  M J, Hoffmann P . Intrathecal L-baclofen for cerebral spasticity: case report.  Neurology . 1995;  45 2110-2111
    PubMedGoogle Scholar
  • 74 Gerszten P C, Albright A L, Barry  M J. Effect on ambulation of continuous intrathecal baclofen infusion.   Pediatric Neurosurgery . 1997;  27 40-44
    PubMedGoogle Scholar
  • 75 Gerszten P C, Albright A L, Johnstone  G F. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy.  Journal of Neurosurgery . 1998;  88 1009-1013
    PubMedGoogle Scholar
  • 76 Gilmartin R , Rawlins  P . Seizures in epileptic cerebral palsy patients receiving intrathecal baclofen infusion.   Epilepsia . 1995;  36 S12
    PubMedGoogle Scholar
  • 77 Krach  L , Gilmartin R , Bruce  D , Storrs B , Abbott  R , Ward J . Functional changes noted following treatments of individuals with cerebral palsy with intrathecal baclofen.  Developmental Medicine and Child Neurology . 1997;  39(suppl 75) S12-S13
    PubMedGoogle Scholar
  • 78 Latash  M L, Penn R D. Changes in voluntary motor control induced by intrathecal baclofen in patients with spasticity of different etiology.   Physiotherapy Research International . 1996;  1 229-246
    PubMedGoogle Scholar
  • 79 Penn R D, Gianino J M, York M M. Intrathecal baclofen for motor disorders.  Movement Disorders . 1995;  10 675-677
    CrossrefPubMedGoogle Scholar
  • 80 Steinbok P D, Danesh H M, Evans D M, Kestle J R. Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy.   Pediatric Neurosurgery . 1995;  22 255-264
    PubMedGoogle Scholar
  • 81 Almeida G L, Campbell S K, Girolami G L, Penn R D, Corcos D M. Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen.  Physical Therapy . 1997;  77 751-764
    PubMedGoogle Scholar
  • 82 Gilmartin R , Bruce  D , Storrs B B. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial.  Journal of Child Neurology . 2000;  15 71-77
    PubMedGoogle Scholar
  • 83 Butler C , Campbell S . Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy.AACPDM Treatment Outcomes Committee Review Panel.  Developmental Medicine & Child Neurology . 2000;  42 634-645
    PubMedGoogle Scholar
  • 84 Ford B , Greene  P , Louis E D. Use of intrathecal baclofen in the treatment of patients with dystonia.   Archives of Neurology . 1996;  53 1241-1246
    PubMedGoogle Scholar
  • 85 Albright A L, Barry  M J, Painter M J, Shultz  B . Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy.   Journal of Neurosurgery . 1998;  88 73-76
    PubMedGoogle Scholar
  • 86 Penn R D. Intrathecal baclofen for spasticity of spinal origin: seven years of experience.  Journal of Neurosurgery . 1992;  77 236-240
    PubMedGoogle Scholar
  • 87 Kofler M , Kronenberg M F, Rifici  C , Saltuari L , Bauer  G . Epileptic seizures associated with intrathecal baclofen application.  Neurology . 1994;  44 25-27
    CrossrefPubMedGoogle Scholar
  • 88 Rifici C , Kofler M , Kronenberg M F, Kofler A , Bramanti P , Saltuari L . Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury.   Functional Neurology . 1994;  9 29-34
    PubMedGoogle Scholar
  • 89 Lazorthes Y , Sallerin-Caute  B F, Verdie J C, Bastide R , Carillo J P. Chronic intrathecal baclofen administration for control of severe spasticity.   Journal of Neurosurgery . 1990;  72 393-402
    PubMedGoogle Scholar
  • 90 Muller-Schwefe  GR , Penn R D. Physostigmine in the treatment of intrathecal baclofen overdose: report of three cases.  Journal of Neurosurgery . 1989;  71 273-275
    PubMedGoogle Scholar
  • 91 Saltuari L , Baumgartner H , Kofler M . Failure of physostigmine in treatment of acute severe intrathecal baclofen intoxication.  New England Journal of Medicine . 1990;  322 1533-1534
    PubMedGoogle Scholar
  • 92 Delhaas E M, Brouwers J R. Intrathecal baclofen overdose: report of 7 events in 5 patients and review of the literature.   International Journal of Clinical Pharmacology, Therapy, & Toxicology . 1991;  29 274-280
    PubMedGoogle Scholar
  • 93 Kofler M , Arturo  L A. Prolonged seizure activity after baclofen withdrawal.  Neurology . 1992;  42 697-698
    PubMedGoogle Scholar
  • 94 Mandac B R, Hurvitz E A, Nelson  V S. Hyperthermia associated with baclofen withdrawal and increased spasticity.  Archives of Physical Medicine and Rehabilitation . 1993;  74 96-97
    PubMedGoogle Scholar
  • 95 Reeves R K, Stolp-Smith K A, Christopherson M W. Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure.   Archives of Physical Medicine & Rehabilitation . 1998;  79 353-356
    PubMedGoogle Scholar
  • 96 Siegfried R N, Jacobson L , Chabal C . Development of an acute withdrawal syndrome following the cessation of intrathecal baclofen in a patient with spasticity.  Anesthesiology . 1992;  77 1048-1050
    PubMedGoogle Scholar
  • 97 Khorasani A , Peruzzi W T. Dantrolene treatment for abrupt intrathecal baclofen withdrawal.  Anesthesia & Analgesia . 1995;  80 1054-1056
    PubMedGoogle Scholar
  • 98 Gardner B , Jamous A , Teddy P . Intrathecal baclofen: a multicentre clinical comparison of the Medtronics Programmable, Cordis Secor and Constant Infusion Infusaid drug delivery systems.  Paraplegia . 1995;  33 551-554
    PubMedGoogle Scholar
  • 99 Penn R D, York M M, Paice J A. Catheter systems for intrathecal drug delivery.   Journal of Neurosurgery . 1995;  83 215-217
    PubMedGoogle Scholar
  • 100 Müller  H . Treatment of severe spasticity: results of a multicenter trial conducted in Germany involving the intrathecal infusion of baclofen by an implantable drug delivery system.  In: Lakke JPWF, Delhaas EM, Rutgers AWF, eds. Parenteral Drug Therapy in Spasticity and Parkinson's Disease. Lancaster: Parthenon 1992: 103-113
    Google Scholar
  • 101 Hugenholtz H D, Nelson R F, Dehoux E . Intrathecal baclofen: the importance of catheter position.   Canadian Journal of Neurological Sciences . 1993;  20 165-167
    PubMedGoogle Scholar